01 Aug 2022 Policy
One Cancer Voice writes to Sajid Javid ahead of 10-Year Cancer Plan
Today, with over 50 cancer charities, we wrote to the Secretary of State for Health & Social Care, Sajid Javid, to set out our expectation for next month’s 10-Year Cancer Plan.
The 10-Year Cancer Plan must include robust, fully costed and funded plans to deliver on its ambitions, and set out how it will address shortages in workforce and equipment – key hurdles that have hindered previous commitments and strategies.
We are writing alongside other charities including Blood Cancer UK, Cancer Research UK and Leukaemia Care, to urge Sajid Javid to ensure the plan meets the ten essential tests we set out in our submission as being ‘essential to deliver on your ambition of having the best cancer care in Europe.’
The key tests to which the whole cancer community will hold this 10-Year Cancer Plan include, ensuring the plan is fully planned, costed and funded, that there are no more shortages in the cancer workforce, and that it matches ambition with accountability.
This 10-Year Cancer Plan comes at a very important time for those affected by cancer in England, with the continued ‘devastating impact of the pandemic on cancer services’ – particularly on waiting times for care.
New survey data from Cancer Research UK shows that 3 in 4 (75%) adults in the UK don’t think the NHS has enough staff or equipment to deal with cancer. Rising cancer incidence over the 10 years of the Plan indicates the challenge ‘is only set to grow – meaning tangible, decisive action is needed now.’
We urge Sajid Javid to ensure the 10-Year Cancer Plan meets these tests, if it is to have the full support, belief and backing of the wider cancer community.
Related posts
24 September 2021
Leading leukaemia charities call on Rishi Sunak not to cut financial lifeline for blood cancer patients
Leukaemia Care, Leukaemia UK and Leukaemia and Lymphoma Northern Ireland, have written to the Chancellor urging him to realise the devastating impact the end of the Coronavirus Job Retention Scheme will have on the clinically extremely vulnerable (CEV).
21 May 2020
A new clinical trial announced
A study into the impact of severe covid-19 infection on patients who receive stem cell transplants for blood cancers and blood disorders.
22 May 2023
Can the unique differences between stem cells tell us how well CML treatment will work?
What if we could predict how chronic myeloid leukaemia (CML) patients will respond to treatment? Could the unique signatures of CML stem cells hold the key to personalising treatment for…
9 May 2018
Sharing this exciting news: a treatment advance for childhood leukaemia
A deal has been struck to let the NHS offer children an expensive new cancer therapy that has been called the most exciting treatment advance for decades